6:11 PM
 | 
Sep 25, 2013
 |  BC Extra  |  Company News

EC approves Boehringer's Giotrif for NSCLC

The European Commission approved an MAA from Boehringer Ingelheim GmbH (Ingelheim, Germany) for Giotrif afatinib to...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >